The IgG4-related disease market is growing as awareness increases, diagnostic methods improve, and the condition is more widely recognized. Companies such as AstraZeneca, Horizon Therapeutics, and InflaRx are advancing therapies focused on immune system regulation. Rising diagnosis rates, ongoing clinical research, and efforts to improve treatment approaches are helping shape progress in this space.
Access Market Report: https://shorturl.at/bAPNy
Comment
Share
